Compare BBOT & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBOT | NVRI |
|---|---|---|
| Founded | 2016 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 996.0M |
| IPO Year | N/A | N/A |
| Metric | BBOT | NVRI |
|---|---|---|
| Price | $13.69 | $18.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | 168.9K | ★ 2.6M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,244,061,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.50 | $4.72 |
| 52 Week High | $14.78 | $18.74 |
| Indicator | BBOT | NVRI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 80.47 |
| Support Level | N/A | $18.13 |
| Resistance Level | N/A | $18.47 |
| Average True Range (ATR) | 0.00 | 0.47 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 0.00 | 89.18 |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.